Injectable drugs require refrigeration when they are stored or transported, and the pill potentially opens up the market ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

Three medical spas around the Valley, along with others in the state, were named by Attorney General Dave Yost for making ...

Ohio Attorney General Dave Yost has sent letters to 14 medical spas throughout the state warning them to stop making false or ...

Ohio Attorney General Dave Yost has sent letters to 14 medical spas saying they should stop making false or misleading claims ...

Several Ohio medical spas including two in the Mahoning Valley were sent letters by the Ohio Attorney General's Office ...

Presentation Title: Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass and Physical Function in Older Patients Receiving Semaglutide for Weight Loss Date: April 30, 2025 Start time: 12:30 ...

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The Ozempic 6 week belly weight reduction program is an effective way to shed those unwanted pounds and promote your overall ...

A daily pill developed by Eli Lilly significantly lowered blood sugar levels and led to weight loss in people with Type 2 ...